Juno halts planned sale of Velcade generic in settlement with Millennium, US
Intellectual Property March 24, 2020 11:08 am By Christine Caulfield | Melbourne

Generic drug maker Juno Pharmaceuticals has agreed to stopped planned sales of its cheap version of Millennium Pharmaceuticals anti-cancer medication Velcade in Australia as part […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.